Klausner Arthur J's Form 4 filing
Monopar Therapeutics (MNPR) · filed Dec 19, 2025
- Accession no.
- 0001437749-25-038426
- Filed
- Dec 19, 2025
- Trade date
- Dec 18, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $343.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klausner Arthur JCIK 0001207790 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Common Stock | SSaleDisposed | −4,660 | $67.06 | −$312,499.6 | 9,223 | Direct | |
| Dec 18, 2025 | Common Stock | SSaleDisposed | −461 | $68.09 | −$31,389.49 | 8,762 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.